Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)

Clinical trial NCT04841369 · COMPLETED

Trial details

NCT number: NCT04841369
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Infections Streptococcal Infections Bacterial Infections

Start date: 2021-04-13
Primary completion: 2022-03-30
Enrollment: 3420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.